Skip to main content
Top
Published in: Dermatology and Therapy 2/2023

Open Access 14-12-2022 | Atopic Dermatitis | Original Research

Impact of Patient and Physician Disconnect on Satisfaction with Treatment for Atopic Dermatitis in Japan

Authors: Chaochen Wang, Toshihiko Aranishi, Catherine Reed, Peter Anderson, Jenny Austin, Victoria A. Davis, Emily Quinones, James Piercy

Published in: Dermatology and Therapy | Issue 2/2023

Login to get access

Abstract

Introduction

Atopic dermatitis (AD) is an inflammatory disease causing severe skin itching. Data on patient–physician disconnect on treatment satisfaction in patients with AD in Japan are limited. We investigated patient–physician disconnect on treatment satisfaction in AD and if it influences treatment patterns, clinical characteristics, and patient-reported outcomes (PROs).

Methods

Data were drawn from the Adelphi AD Disease Specific Programme (DSP), a real-world, point-in-time survey of physicians and patients with AD conducted in Japan from April to July 2019. Patients and physicians were grouped according to level of treatment satisfaction (“extremely satisfied” to “extremely dissatisfied”); with any level of dissatisfaction recorded as “less than satisfied.” Data were collected on treatment patterns, clinical characteristics, and PROs including the Dermatology Life Quality Index (DLQI), Patient-Oriented Eczema Measure (POEM), EQ-5D-3L questionnaire, and Work Productivity and Activity Impairment (WPAI) questionnaire.

Results

Data were provided by 184 patients with AD and 56 physicians; 72.8% of patient–physician pairs reported a fair (kappa coefficient: 0.40) level of agreement on treatment satisfaction, 51.6% of patient–physician pairs were both satisfied, and 21.2% were both less than satisfied. Satisfied physicians prescribed a mean 1.2 fewer treatments than dissatisfied physicians (p < 0.05). Cases where both physician and patient were less than satisfied or where patients were less satisfied than their physicians reported the worst PROs, DLQI (both less than satisfied: mean 10.7 versus patient less satisfied than physician: 10.6 versus overall: 7.9), POEM (19.5 versus 17.3 versus 17.0), EQ-5D-3L (0.82 versus 0.81 versus 0.87) (all, p < 0.05). Work impairment was highest when both patient and physician were less than satisfied (p < 0.05). Physicians cited treatment efficacy and patients cited efficacy and usability as main reasons for dissatisfaction.

Conclusion

Overall, 12.0% of patients were less satisfied with their AD treatment than the physician, demonstrating some of the worst PROs, suggesting unmet need that could be improved by better patient–physician communication.
Literature
1.
go back to reference Simpson EL, Paller AS, Siegfried EC, Boguniewicz M, Sher L, Gooderham MJ, Beck LA, Guttman-Yassky E, Pariser D, Blauvelt A, et al. Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis: a phase 3 randomized clinical trial. JAMA Dermatol. 2020;156(1):44–56.CrossRef Simpson EL, Paller AS, Siegfried EC, Boguniewicz M, Sher L, Gooderham MJ, Beck LA, Guttman-Yassky E, Pariser D, Blauvelt A, et al. Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis: a phase 3 randomized clinical trial. JAMA Dermatol. 2020;156(1):44–56.CrossRef
2.
go back to reference Na CH, Chung J, Simpson EL. Quality of life and disease impact of atopic dermatitis and psoriasis on children and their families. Child (Basel). 2019;6(12):133. Na CH, Chung J, Simpson EL. Quality of life and disease impact of atopic dermatitis and psoriasis on children and their families. Child (Basel). 2019;6(12):133.
3.
go back to reference Barbeau M, Lalonde H. Burden of atopic dermatitis in Canada. Int J Dermatol. 2006;45(1):31–6.CrossRef Barbeau M, Lalonde H. Burden of atopic dermatitis in Canada. Int J Dermatol. 2006;45(1):31–6.CrossRef
4.
go back to reference Vakharia PP, Chopra R, Sacotte R, Patel KR, Singam V, Patel N, Immaneni S, White T, Kantor R, Hsu DY et al. Burden of skin pain in atopic dermatitis. Ann Allergy Asthma Immunol. 2017;119(6):548–552 e543. Vakharia PP, Chopra R, Sacotte R, Patel KR, Singam V, Patel N, Immaneni S, White T, Kantor R, Hsu DY et al. Burden of skin pain in atopic dermatitis. Ann Allergy Asthma Immunol. 2017;119(6):548–552 e543.
5.
go back to reference Furue M, Chiba T, Takeuchi S. Current status of atopic dermatitis in Japan. Asia Pac Allergy. 2011;1(2):64–72.CrossRef Furue M, Chiba T, Takeuchi S. Current status of atopic dermatitis in Japan. Asia Pac Allergy. 2011;1(2):64–72.CrossRef
6.
go back to reference Tanaka A, Morioke S, Ohya Y, Shimojo N, Takahashi M, Tanaka M, Takahagi S, Kan T, Iwamoto K, Saito R, et al. Comparison of the time course of atopic dermatitis from birth to 19 years old among generations of patients in Japan. J Dermatol. 2021;48(10):1602–6.CrossRef Tanaka A, Morioke S, Ohya Y, Shimojo N, Takahashi M, Tanaka M, Takahagi S, Kan T, Iwamoto K, Saito R, et al. Comparison of the time course of atopic dermatitis from birth to 19 years old among generations of patients in Japan. J Dermatol. 2021;48(10):1602–6.CrossRef
7.
go back to reference Muto T, Hsieh SD, Sakurai Y, Yoshinaga H, Suto H, Okumura K, Ogawa H. Prevalence of atopic dermatitis in Japanese adults. Br J Dermatol. 2003;148(1):117–21.CrossRef Muto T, Hsieh SD, Sakurai Y, Yoshinaga H, Suto H, Okumura K, Ogawa H. Prevalence of atopic dermatitis in Japanese adults. Br J Dermatol. 2003;148(1):117–21.CrossRef
8.
go back to reference Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, Gieler U, Lipozencic J, Luger T, Oranje AP, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) Part I. J Eur Acad Dermatol Venereol. 2012;26(8):1045–60.CrossRef Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, Gieler U, Lipozencic J, Luger T, Oranje AP, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) Part I. J Eur Acad Dermatol Venereol. 2012;26(8):1045–60.CrossRef
9.
go back to reference Saeki H, Nakahara T, Tanaka A, Kabashima K, Sugaya M, Murota H, Ebihara T, Kataoka Y, Aihara M, Etoh T, et al. Clinical practice guidelines for the management of atopic dermatitis 2016. J Dermatol. 2016;43(10):1117–45.CrossRef Saeki H, Nakahara T, Tanaka A, Kabashima K, Sugaya M, Murota H, Ebihara T, Kataoka Y, Aihara M, Etoh T, et al. Clinical practice guidelines for the management of atopic dermatitis 2016. J Dermatol. 2016;43(10):1117–45.CrossRef
10.
go back to reference Katayama I, Aihara M, Ohya Y, Saeki H, Shimojo N, Shoji S, Taniguchi M, Yamada H. Japanese guidelines for atopic dermatitis 2017. Allergol Int. 2017;66(2):230–47.CrossRef Katayama I, Aihara M, Ohya Y, Saeki H, Shimojo N, Shoji S, Taniguchi M, Yamada H. Japanese guidelines for atopic dermatitis 2017. Allergol Int. 2017;66(2):230–47.CrossRef
11.
go back to reference Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN, Chamlin SL, Cooper KD, Feldman SR, Hanifin JM et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327–349 Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN, Chamlin SL, Cooper KD, Feldman SR, Hanifin JM et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327–349
12.
go back to reference Kamei K, Saeki H, Tsuchiya T, Hirose T, Campos-Alberto E, Matsumoto F, Yoshii N, Imafuku S. Real-world treatment patterns of patients with atopic dermatitis in Japan: analysis of the JMDC claims database. J Cutane Immunology and Allergy. 2021;4(5):109–19.CrossRef Kamei K, Saeki H, Tsuchiya T, Hirose T, Campos-Alberto E, Matsumoto F, Yoshii N, Imafuku S. Real-world treatment patterns of patients with atopic dermatitis in Japan: analysis of the JMDC claims database. J Cutane Immunology and Allergy. 2021;4(5):109–19.CrossRef
13.
go back to reference Silverberg JI, Simpson EL, Wollenberg A, Bissonnette R, Kabashima K, DeLozier AM, Sun L, Cardillo T, Nunes FP, Reich K. Long-term efficacy of baricitinib in adults with moderate to severe atopic dermatitis who were treatment responders or partial responders: an extension study of 2 randomized clinical trials. JAMA Dermatol. 2021;157(6):691–9.CrossRef Silverberg JI, Simpson EL, Wollenberg A, Bissonnette R, Kabashima K, DeLozier AM, Sun L, Cardillo T, Nunes FP, Reich K. Long-term efficacy of baricitinib in adults with moderate to severe atopic dermatitis who were treatment responders or partial responders: an extension study of 2 randomized clinical trials. JAMA Dermatol. 2021;157(6):691–9.CrossRef
14.
go back to reference Furst DE, Tran M, Sullivan E, Pike J, Piercy J, Herrera V, Palmer JB. Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control. Clin Rheumatol. 2017;36(9):2045–54.CrossRef Furst DE, Tran M, Sullivan E, Pike J, Piercy J, Herrera V, Palmer JB. Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control. Clin Rheumatol. 2017;36(9):2045–54.CrossRef
15.
go back to reference Dunn A, Litrivis E. Aligning patient preferences and patient care at the end of life. J Gen Intern Med. 2011;26(7):681–2.CrossRef Dunn A, Litrivis E. Aligning patient preferences and patient care at the end of life. J Gen Intern Med. 2011;26(7):681–2.CrossRef
16.
go back to reference Kuluski K, Gill A, Naganathan G, Upshur R, Jaakkimainen RL, Wodchis WP. A qualitative descriptive study on the alignment of care goals between older persons with multi-morbidities, their family physicians and informal caregivers. BMC Fam Pract. 2013;14:133–133.CrossRef Kuluski K, Gill A, Naganathan G, Upshur R, Jaakkimainen RL, Wodchis WP. A qualitative descriptive study on the alignment of care goals between older persons with multi-morbidities, their family physicians and informal caregivers. BMC Fam Pract. 2013;14:133–133.CrossRef
17.
go back to reference Wei W, Anderson P, Gadkari A, Blackburn S, Moon R, Piercy J, Shinde S, Gomez J, Ghorayeb E. Discordance between physician- and patient-reported disease severity in adults with atopic dermatitis: a US cross-sectional survey. Am J Clin Dermatol. 2017;18(6):825–35.CrossRef Wei W, Anderson P, Gadkari A, Blackburn S, Moon R, Piercy J, Shinde S, Gomez J, Ghorayeb E. Discordance between physician- and patient-reported disease severity in adults with atopic dermatitis: a US cross-sectional survey. Am J Clin Dermatol. 2017;18(6):825–35.CrossRef
18.
go back to reference Nakahara T, Fujita H, Arima K, Taguchi Y, Motoyama S, Furue M. Perception gap between patients and physicians regarding disease burden and treatment satisfaction in atopic dermatitis: findings from an on-line survey. Jpn J Dermatol. 2018;128(13):2843–55. Nakahara T, Fujita H, Arima K, Taguchi Y, Motoyama S, Furue M. Perception gap between patients and physicians regarding disease burden and treatment satisfaction in atopic dermatitis: findings from an on-line survey. Jpn J Dermatol. 2018;128(13):2843–55.
19.
go back to reference Okubo Y, Ho K-A, Fifer S, Fujita H, Oki Y, Taguchi Y. Patient and physician preferences for atopic dermatitis injection treatments in Japan. J Dermatol Treat. 2020;31(8):821–30.CrossRef Okubo Y, Ho K-A, Fifer S, Fujita H, Oki Y, Taguchi Y. Patient and physician preferences for atopic dermatitis injection treatments in Japan. J Dermatol Treat. 2020;31(8):821–30.CrossRef
20.
go back to reference Kamei K, Hirose T, Yoshii N, Tanaka A. Burden of illness, medication adherence, and unmet medical needs in Japanese patients with atopic dermatitis: a retrospective analysis of a cross-sectional questionnaire survey. J Dermatol. 2021;48(10):1491–8.CrossRef Kamei K, Hirose T, Yoshii N, Tanaka A. Burden of illness, medication adherence, and unmet medical needs in Japanese patients with atopic dermatitis: a retrospective analysis of a cross-sectional questionnaire survey. J Dermatol. 2021;48(10):1491–8.CrossRef
21.
go back to reference Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-world physician and patient behaviour across countries: disease-specific programmes—a means to understand. Curr Med Res Opin. 2008;24(11):3063–72.CrossRef Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-world physician and patient behaviour across countries: disease-specific programmes—a means to understand. Curr Med Res Opin. 2008;24(11):3063–72.CrossRef
22.
go back to reference Babineaux SM, Curtis B, Holbrook T, Milligan G, Piercy J. Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme. BMJ Open. 2016;6(8): e010352.CrossRef Babineaux SM, Curtis B, Holbrook T, Milligan G, Piercy J. Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme. BMJ Open. 2016;6(8): e010352.CrossRef
23.
go back to reference Finlay AY, Khan GK. Dermatology life quality index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–6.CrossRef Finlay AY, Khan GK. Dermatology life quality index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–6.CrossRef
24.
go back to reference Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients’ perspective. Arch Dermatol. 2004;140(12):1513–9.CrossRef Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients’ perspective. Arch Dermatol. 2004;140(12):1513–9.CrossRef
25.
go back to reference Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–65.CrossRef Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–65.CrossRef
26.
go back to reference EuroQol Group. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.CrossRef EuroQol Group. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.CrossRef
27.
go back to reference Shiroiwa T, Fukuda T, Ikeda S, Igarashi A, Noto S, Saito S, Shimozuma K. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res. 2016;25(3):707–19.CrossRef Shiroiwa T, Fukuda T, Ikeda S, Igarashi A, Noto S, Saito S, Shimozuma K. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res. 2016;25(3):707–19.CrossRef
29.
go back to reference McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276–82.CrossRef McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276–82.CrossRef
30.
go back to reference Griffiths CEM, Augustin M, Naldi L, Romiti R, Guevara-Sangines E, Howe T, Pietri G, Gilloteau I, Richardson C, Tian H, et al. Patient-dermatologist agreement in psoriasis severity, symptoms and satisfaction: results from a real-world multinational survey. J Eur Acad Dermatol Venereol. 2018;32(9):1523–9.CrossRef Griffiths CEM, Augustin M, Naldi L, Romiti R, Guevara-Sangines E, Howe T, Pietri G, Gilloteau I, Richardson C, Tian H, et al. Patient-dermatologist agreement in psoriasis severity, symptoms and satisfaction: results from a real-world multinational survey. J Eur Acad Dermatol Venereol. 2018;32(9):1523–9.CrossRef
31.
go back to reference Asai A, Okita T, Bito S. Discussions on present Japanese psychocultural-social tendencies as obstacles to clinical shared decision-making in Japan. Asian Bioeth Rev. 2022;14(2):133–50.CrossRef Asai A, Okita T, Bito S. Discussions on present Japanese psychocultural-social tendencies as obstacles to clinical shared decision-making in Japan. Asian Bioeth Rev. 2022;14(2):133–50.CrossRef
32.
go back to reference Asai A. Should physicians tell patients the truth? West J Med. 1995;163(1):36–9. Asai A. Should physicians tell patients the truth? West J Med. 1995;163(1):36–9.
Metadata
Title
Impact of Patient and Physician Disconnect on Satisfaction with Treatment for Atopic Dermatitis in Japan
Authors
Chaochen Wang
Toshihiko Aranishi
Catherine Reed
Peter Anderson
Jenny Austin
Victoria A. Davis
Emily Quinones
James Piercy
Publication date
14-12-2022
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 2/2023
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-022-00866-z

Other articles of this Issue 2/2023

Dermatology and Therapy 2/2023 Go to the issue